Organon & Co.
OGN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,602 | $1,594 | $1,513 | $1,592 |
| % Growth | 0.5% | 5.4% | -5% | – |
| Cost of Goods Sold | $745 | $720 | $672 | $696 |
| Gross Profit | $857 | $874 | $841 | $896 |
| % Margin | 53.5% | 54.8% | 55.6% | 56.3% |
| R&D Expenses | $84 | $95 | $96 | $130 |
| G&A Expenses | $0 | $0 | $0 | $262 |
| SG&A Expenses | $415 | $453 | $420 | $470 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $206 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $499 | $548 | $516 | $600 |
| Operating Income | $358 | $326 | $325 | $296 |
| % Margin | 22.3% | 20.5% | 21.5% | 18.6% |
| Other Income/Exp. Net | -$115 | -$97 | -$224 | -$167 |
| Pre-Tax Income | $243 | $229 | $101 | $129 |
| Tax Expense | $83 | $84 | $14 | $20 |
| Net Income | $160 | $145 | $87 | $109 |
| % Margin | 10% | 9.1% | 5.8% | 6.8% |
| EPS | 0.62 | 0.56 | 0.34 | 0.42 |
| % Growth | 10.7% | 64.7% | -19% | – |
| EPS Diluted | 0.61 | 0.56 | 0.33 | 0.42 |
| Weighted Avg Shares Out | 260 | 260 | 258 | 258 |
| Weighted Avg Shares Out Dil | 261 | 260 | 261 | 260 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $128 | $132 | $124 | $132 |
| Depreciation & Amortization | $89 | $89 | $100 | $76 |
| EBITDA | $460 | $449 | $325 | $341 |
| % Margin | 28.7% | 28.2% | 21.5% | 21.4% |